Kristaps Porziņģis’s Health and Future with the Golden State Warriors
The Golden State Warriors’ acquisition of Kristaps Porziņģis in February 2026 brought both excitement and uncertainty. While Porziņģis showcased promising potential in his debut, a recurring and somewhat mysterious illness has sidelined him, raising questions about his availability and long-term future with the team.
Porziņģis’s Promising Debut
Porziņģis made his Warriors debut on February 19, 2026, after being traded from the Atlanta Hawks. Despite having been out for over a month, he demonstrated flashes of his potential, scoring 12 points in 17 minutes of play. He displayed the floor-stretching and rim-protecting abilities that earned him the nickname “Unicorn” during his time with the New York Knicks. Stephen Curry noted Porziņģis brought a much-needed size and presence to the team, being the tallest teammate he has ever had. In the 9 minutes and 48 seconds he played, the Warriors outscored their opponents by 15 points.
A Recurring Illness and Diagnosis
Shortly after his debut, Porziņģis began experiencing illness, leading to an extended absence. He was initially diagnosed with postural orthostatic tachycardia syndrome (POTS), an autonomic condition that can cause an increased heart rate, dizziness, and fatigue. He had been diagnosed with POTS in 2025 after contracting a viral upper respiratory illness while playing for the Boston Celtics. He described the feeling as persistent exhaustion, even after rigorous training and attempts to manage the condition through hydration, nutrition, and sleep.
Conflicting Information and Uncertainty
The nature of Porziņģis’s illness has been a source of confusion. Warriors coach Steve Kerr described the situation as “mysterious” and expressed hope for clarity regarding his condition. There was even conflicting information regarding his POTS diagnosis, with Kerr initially stating, based on a conversation with his former colleague at the Hawks, that Porziņģis was not dealing with POTS, a statement he later retracted, acknowledging it was a “stupid mistake” and deferring to medical professionals. Porziņģis himself acknowledged a connection between his current illness and his POTS diagnosis, stating, “Somewhat, yes,” when asked if the two were related.
Return to Play and Future Outlook
Porziņģis returned to the Warriors lineup on March 7, 2026, after a six-game absence, playing 23 minutes against the Oklahoma City Thunder and recording 9 points, 5 rebounds, and 5 assists. He expressed optimism about his body’s recovery and his ability to stay on the court, stating he felt his body was “coming back to where I need to be.”
Impact on the Warriors
Porziņģis’s health issues come at a critical time for the Warriors, who are already dealing with injuries to key players like Jimmy Butler (ACL tear) and Stephen Curry (knee problems). The combined salaries of these injured players total $144.4 million, while the team currently occupies a play-in spot. The Warriors traded Jonathan Kuminga and Buddy Hield to acquire Porziņģis, hoping he would be a key contributor, but his availability remains a significant concern.
Looking Ahead
As an unrestricted free agent this summer, Porziņģis’s health will undoubtedly impact his market value. The Warriors retain flexibility with their future draft picks and could explore potential trades, but his ability to consistently contribute on the court will be crucial for both his future and the team’s success. The Warriors are focused on supporting Porziņģis and allowing him to return when he is fully healthy, emphasizing a team-first approach and avoiding pressure for a quick return.